Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3293596 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL10466943 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL9635609 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL27975925 | 0.87 | MAPT (0.60) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL20722208 | 0.87 | MAPT (0.60) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL25381943 | 0.87 | MAPT (0.60) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL27548463 | 0.87 | MAPT (0.60) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL20722247 | 0.87 | MAPT (0.60) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL7791417 | 0.86 | MAPT (0.56) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL20912969 | 0.86 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4959472-A | Process for preparing substantially pure diastereoisomers of tetrahydrofolic derivatives | UNIVERSITY OF STRATHCLYDE (GB) | 1990-09-25 | — | — | US | claimed |
| CN-118240011-A | Polypeptide conjugates for treating central nervous system injury | 拜西欧斯（北京）生物技术有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118240010-A | Conjugates comprising camphol and a peptide for the treatment of central nervous system injury | 拜西欧斯（北京）生物技术有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118240009-A | Polypeptide conjugates and uses thereof | 拜西欧斯（北京）生物技术有限公司 | 2024-06-25 | — | — | CN | disclosed |